Chance New York county Dallas city Plano community stage show Gay Provident Platform Chance New York county Dallas city Plano

Stage of redemption

Reading now: 361
dallasvoice.com

Second Chance Players actors rehearse for their inaugural show Bill W. and Dr. Bob which runs Feb. 16- 25. (Photo via Instagram) Theater company offers second chances for those in recovery RICH LOPEZ | Staff writer rich@dallasvoice.com A new theater company officially enters the landscape Feb.

25 with its inaugural performance. While a community theater at heart, Second Chance Players is also a safe space. SCP founder and Executive Director Bill Shea leads this group that provides a creative theater outlet for those in recovery.

For its first show, the company is staging Bill W. and Dr. Bob, a play that tells the story of the two men who pioneered Alcoholics Anonymous and their wives who founded Al-Anon.

Exploring the journey of recovery, the show certainly introduces SCP and its mission. “Our goal is to provide a platform for individuals in recovery to share their stories, heal through artistic expression and break down stigmas surrounding addiction,” Shea said in a press release announcing the show, which he also directs and stars in. “This first production is a testament to the resilience and creativity that arise when individuals are given a second chance.” ……………….. ‘Bill W.

Read more on dallasvoice.com
The website meaws.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

16.03 / 00:39
PReP Life hiv An “ultra” PrEP injection just three times a year could be on the way
Subscribe to our newsletter for a refreshing cocktail (or mocktail) of LGBTQ+ entertainment and pop culture, served up with a side of eye-candy.The new form of the drug is called “cabotegravir ultra long-acting” (CAB-ULA).ViiV presented its findings last week at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) in Denver, Colorado.The trial included 70 participants. Researchers tested injecting the new formulation of the drug.
DMCA